Abstract
Huntington's disease is a progressive neurodegenerative disease in which the molecular abnormality has recently been described. Before the availability of this molecular marker diagnosis depended on clinical findings, supported in some instances by neuroimaging using CT or MRI. The imaging modalities may show atrophy of the heads of caudate nuclei in affected people. An attempt was made to validate these imaging findings using the molecular test as "gold standard." Retrospective analysis of cranial CT in 16 patients with Huntington's disease and 16 age and sex matched controls was performed. There was a highly significant difference in caudate head size (P < 0.00001) between patients with Huntington's disease and control subjects. However, the sensitivity of diagnosis based on radiological examination alone was only 87.5% in this study. Thus the sensitivity of CT is insufficient to justify its routine use in the investigation of suspected Huntington's disease, unless genetic tests are negative and other diagnoses need to be excluded.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aylward E. H., Brandt J., Codori A. M., Mangus R. S., Barta P. E., Harris G. J. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology. 1994 May;44(5):823–828. doi: 10.1212/wnl.44.5.823. [DOI] [PubMed] [Google Scholar]
- Bamford K. A., Caine E. D., Kido D. K., Plassche W. M., Shoulson I. Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology. 1989 Jun;39(6):796–801. doi: 10.1212/wnl.39.6.796. [DOI] [PubMed] [Google Scholar]
- Barr A. N., Heinze W. J., Dobben G. D., Valvassori G. E., Sugar O. Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy. Neurology. 1978 Nov;28(11):1196–1200. doi: 10.1212/wnl.28.11.1196. [DOI] [PubMed] [Google Scholar]
- Bruyn R. P., Hageman G., Geelen J. A., van der Weel F. A., Rozeboom A. R., Barkhof F., Scheltens P. SPECT, CT and MRI in a Turkish family with Huntington's disease. Neuroradiology. 1993;35(7):525–528. doi: 10.1007/BF00588713. [DOI] [PubMed] [Google Scholar]
- Grafton S. T., Mazziotta J. C., Pahl J. J., St George-Hyslop P., Haines J. L., Gusella J., Hoffman J. M., Baxter L. R., Phelps M. E. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Ann Neurol. 1990 Nov;28(5):614–621. doi: 10.1002/ana.410280503. [DOI] [PubMed] [Google Scholar]
- Lang C. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease? Neuroradiology. 1985;27(2):161–163. doi: 10.1007/BF00343789. [DOI] [PubMed] [Google Scholar]
- Stober T., Wussow W., Schimrigk K. Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease. Neuroradiology. 1984;26(1):25–28. doi: 10.1007/BF00328198. [DOI] [PubMed] [Google Scholar]
- Terrence C. F., Delaney J. F., Alberts M. C. Computed tomography for Huntington's disease. Neuroradiology. 1977 Jun 27;13(4):173–175. doi: 10.1007/BF00344209. [DOI] [PubMed] [Google Scholar]
- Warner J. P., Barron L. H., Brock D. J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes. 1993 Jun;7(3):235–239. doi: 10.1006/mcpr.1993.1034. [DOI] [PubMed] [Google Scholar]
- Young A. B., Penney J. B., Starosta-Rubinstein S., Markel D. S., Berent S., Giordani B., Ehrenkaufer R., Jewett D., Hichwa R. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol. 1986 Sep;20(3):296–303. doi: 10.1002/ana.410200305. [DOI] [PubMed] [Google Scholar]